Immune tolerance in hemophilia can be modulated by B cell activating factor

A group of scientists have just made a key discovery that could prevent and eradicate immune responses that lead to treatment failure in about one-third of people with severe hemophilia A. Hemophilia is the most common severe inherited bleeding disorder in men. The disease affects 1 in 10,000 males worldwide and results from deficiency of blood clotting factor VIII (FVIII). […]

Read more

Terry White Chemists Meloxicam

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TERRY WHITE CHEMISTS MELOXICAM TABLETS Contains the active ingredient, meloxicam Consumer Medicine Information What is in this leaflet Read this leaflet carefully before taking your medicine This leaflet answers some common questions about meloxicam. It does not contain all the available information. It does not take the […]

Read more

Pentasa Enema

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PENTASA® (MESALAZINE) ENEMA Enema mesalazine Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about PENTASA. It does not contain all the available information.It does not take the place of talking to your doctor or pharmacist. Please read this leaflet before you […]

Read more